TAU researcher launches urgent push to beat corona

Written on |

Dr. Natalia Freund is analyzing immunity of Israelis who have recovered from the virus.

TAU researcher Dr. Natalia Freund and her team have abandoned their everyday work of isolating antibodies for HIV and other infectious diseases to urgently fight and treat COVID-19, the new coronavirus. The highly contagious disease has been declared a global pandemic by the World Health Organization, with almost 200,000 cases worldwide at press time.

Freund, a Senior Lecturer in the Department of Microbiology and Immunology at the Sackler Faculty of Medicine, will analyze blood samples from Israelis who have recovered from COVID-19 (eleven at press time). Working with graduate student Michael Mordekovich, she will use cutting-edge technology to isolate and extract special cells that produce antibodies following infection and immunize us against the virus.  From these cells, she will isolate antibodies against the virus, produce them in her lab and test them for viral inhibition.

Hope for a vaccine

Freund is hopeful that within a few weeks her team will generate an antibody that will be ready for preclinical trials. The anticipated result is a treatment for COVID-19 patients and a candidate for the development of a vaccine, “although these would be ready in a best-case scenario months down the line,” said Dr. Freund.

Dr. Natalia Freund, testing to beat the coronavirus

In attempts to stem the outbreak as soon as possible, she is working intensively with colleagues at TAU as well as at the Chaim Sheba Medical Center (Tel Hashomer Hospital), Tel Aviv Sourasky Medical Center (Ichilov Hospital), Bar-Ilan University and the Institute for Biological Research.

Aside from Dr. Freund, several more scientists at TAU are working on various aspects of COVID-19 in a campus-wide effort to better understand and overcome the virus.

 

Related posts

Hyperbaric Treatment More Effective than Medicines for Fibromyalgia Caused by Head Injury

24 March 2023

Promoting Women in Medicine

9 March 2023

#TAU_WOMEN_POWER

7 March 2023

Researchers Discover Mechanism that Facilitates Formation of Brain Metastases

27 February 2023

Light Pollution is Killing Desert Rodents

10 February 2023

Three Tel Aviv University Researchers Awarded the ERC Proof of Concept (PoC) grants

9 February 2023

Researchers Identify A New Genetic Risk Factor for Age-related Eye Disease

8 February 2023

People With Autism Experience Pain at a Higher Intensity

31 January 2023

Researchers Uncover New Factors Linked to Williams Syndrome

24 January 2023

Lessons in Tolerance and DNA Extraction in Tel Aviv University’s Medical Labs

18 January 2023

Medical Clowns – No Laughing Matter

18 January 2023

Tel Aviv University’s First MedTech Hackathon Sets a High Bar

15 January 2023

Researchers use Smartwatches to Measure Safety of COVID Vaccine

28 December 2022

Tel Aviv University Establishes Multidisciplinary Center for Research of Autoimmune Diseases

18 December 2022

Breakthrough in the Field of Controlled Drug Delivery

16 December 2022

Common Medications May Reduce Risk of Metastases after Colon and Rectal Cancer

9 December 2022

Victoria

Tok Corporate Centre, Level 1,
459 Toorak Road, Toorak VIC 3142
Phone: +61 3 9296 2065
Email: office@aftau.asn.au

New South Wales

Level 22, Westfield Tower 2, 101 Grafton Street, Bondi Junction NSW 2022
Phone: +61 418 465 556
Email: davidsolomon@aftau.org.au

Western Australia

P O Box 36, Claremont,
WA  6010
Phone: :+61 411 223 550
Email: clivedonner@thelinqgroup.com